becton dickinson compani
summari updat model reflect potenti
impact increment fx headwind lower
revenu forecast ex-fx
vast major reduct attribut pandem
headwind reduc sale estim
ex-fx decreas ep estim
yr/yr
yr/yr lower price target base
blend ebitda estim
ep estim sale weight
procedur believ rel well posit
weather near-term challeng environ addit
see pocket upsid potenti busi like diagnost due
increas test previous given
guidanc assum impact expect
manag either lower withdraw guidanc
call may
balanc sheet overview end compani
cash equival total debt
gener estim free cash flow
abl pay down/refin debt pay
annual dividend sharehold forecast slight
increas believ compani
financi flexibl pay down/refin anoth debt
pay dividend
mix exposur portfolio surgeri
peripher intervent pi busi aggreg
total sale larg compris elect procedur expect
impact pandem assum sale
declin segment durat pandem
medic manag solut diabet bioscienc ucc
urolog critic care togeth one-third total sale
assum busi mostli non-elect thu may
modestli affect pandem sale declin
remain nearli sale medic deliveri solut
pharmaceut system preanalyt system diagnost
address mostli essenti healthcar need
materi affect pandem case may see
boost pandem diagnost test
continu next page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
includ bcr acquisit start ep calcul use two method
determin impact prefer convert as-convert
assum mandatori convert prefer convert qtrli ep sum
full year due share count relat convert prefer
compani data secur llc estim reuter
continu previou page
analysi methodolog key assumpt assum impact jan-feb sale
china applic mid-march june sale rest world includ us
model busi start return normal juli modest sale headwind
persist impact busi surgeri pi analysi assum catch
sale lost sale like recoup new
sale forecast assum similar growth rate lower revenu
base plu pandemic-rel catch beyond assum prior top-lin growth rate remain
rel unchang impact assum corpor oper margin lost sale
corpor margin recoup sale latter assum compani
greater abil dial spend
price target
price target base blend ev/ebitda ebitda price-to-earnings
estim risk includ impact uncertainti delay alari approv slower
expect integr bcr slower debt pay unexpect pipelin delay/setback
believ solidli posit deliv mid-singl digit top-lin growth low double-digit
bottom-lin growth forese futur
global medic devic compani oper two key segment medic life
scienc pend bcr acquisit add third leg platform intervent grew
revenu nearli pro forma underli basi
becton dickinson compani
